1207 - EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL). - Ascierto, P.; Bastholt, L.; Mohr, P.; Hoeller, C.; Robert, C.; Larkin, J.; Dummer, R.; Ekbom, A.; Chiarion-Sileni, V.; Dutriaux, C.; Mortier, L.; Neyns, B.; et al. (European Journal of Cancer, 2017)